Download PDF
Synlett 2008(17): 2637-2641  
DOI: 10.1055/s-0028-1083439
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Facile Preparation of Thiazoles from 1H-1-(1′-Alkynyl)-5-methyl-1,2,3-benziodoxathiole 3,3-Dioxide with Thioamides

Yoshihide Ishiwata, Hideo Togo*
Graduate School of Science, Chiba University, Yayoi-cho 1-33, Inage-ku, Chiba 263-8522, Japan
e-Mail: togo@faculty.chiba-u.jp;
Further Information

Publication History

Received 27 June 2008
Publication Date:
01 October 2008 (online)

    Permissions and Reprints All articles of this category

Abstract

Thiazoles were obtained in high yields by the reaction of 1H-1-(1′-alkynyl)-5-methyl-1,2,3-benziodoxathiole 3,3-dioxides, which were easily prepared from the reaction of 1H-1-hydroxy-5-methyl-1,2,3-benziodoxathiole 3,3-dioxide and 1-alkynes, with thioamides. Here, the co-product, potassium 2-iodo-5-methylbenzenesulfonate, was recovered quantitatively by simple filtration of the reaction mixture, and was regenerated to 1H-1-(1′-alkynyl)-5-methyl-1,2,3-benziodoxathiole 3,3-dioxides to be reused for the same preparation of thiazoles, keeping good yields.

Key words

thiazole - 1H-1-(1′-alkynyl)-5-methyl-1,2,3-benziod­oxathiole 3,3-dioxide - 1-alkyne - thioamide

    References and Notes

  • 1a Metzger JV. Comprehensive Heterocyclic Chemistry   Vol. 6:  Katritzky AR. Rees CW. Pergamon; Oxford: 1984.  p.235-331  
    Google Scholar
  • 1b Dondoni A. Merino P. Comprehensive Heterocyclic Chemistry II   Vol. 3:  Katritzky AR. Rees CW. Scriven EFV. Elsevier Science; Oxford: 1996.  p.373-474  
    Google Scholar
  • 1c Boden CDJ. Pattenden G. Ye T. Synlett  1995,  417 
    Google Scholar
  • 1d Wipf P. Chem. Rev.  1995,  95:  2115 
    Google Scholar
  • 1e Dondoni A. Synthesis  1998,  1681 
    Google Scholar
  • 1f Potewar TM. Ingale SA. Srinivasan KV. Tetrahedron  2007,  63:  11066 
    Google Scholar
  • 1g Yadav JS. Reddy BVS. Rao YG. Narsaiah AV. Tetrahedron Lett.  2008,  49:  2381 
    Google Scholar
  • 1h Potewar TM. Ingale SA. Srinivasan KV. Tetrahedron  2008,  64:  5019 
    Google Scholar
  • 2a Haviv F. Ratajczyk JD. DeNet RW. Kerdesky FA. Walters RL. Schmidt SP. Holms JH. Young PR. Carter GW. J. Med. Chem.  1988,  31:  1719 
    Google Scholar
  • 2b Patt WC. Hamilton HW. Taylor MD. Ryan MJ. Taylor DG. Connolly CJC. Doherty AM. Klutchko SR. Sircar I. Steinbaugh BA. Batley BL. Painchaud CA. Rapundalo ST. Michniewicz BM. Olson SCJ. J. Med. Chem.  1992,  35:  2562 
    Google Scholar
  • 2c Tsuji K. Ishikawa H. Bioorg. Med. Chem. Lett.  1994,  4:  1601 
    Google Scholar
  • 2d Bell FW. Cantrell AS. Hoegberg M. Jaskunas SR. Johansson NG. Jordon CL. Kinnick MD. Lind P. Morin JM. Noreen R. Oberg B. Palkowitz JA. Parrish CA. Pranc P. Sahlberg C. Ternansky RJ. Vasileff RT. Vrang L. West SJ. Zhang H. Zhou XX. J. Med. Chem.  1995,  38:  4929 
    Google Scholar
  • 3a Hantzsch A. Weber JH. Ber. Dtsch. Chem. Ges.  1887,  20:  3118 
    Google Scholar
  • 3b Wiley RH. Behr LC. Org. Rec.  1951,  6:  367 
    Google Scholar
  • 4a Koser GF. Wettach RH. J. Org. Chem.  1977,  42:  1476 
    Google Scholar
  • 4b Moriarty RM. Vaid RK. Hopkins TE. Vaid BK. Prakash O. Tetrahedron Lett.  1990,  31:  201 
    Google Scholar
  • 4c Moriarty RM. Vaid RK. Duncan MP. Levy SG. Prakash O. Goyal S. Synthesis  1992,  845 
    Google Scholar
  • 4d Prakash O. Goyal S. Synthesis  1992,  629 
    Google Scholar
  • 4e Prakash O. Rani N. Goyal S. J. Chem. Soc., Perkin Trans. 1  1992,  707 
    Google Scholar
  • 4f Prakash O. Saini N. Sharma PK. Synlett  1994,  221 
    Google Scholar
  • 4g Ueno M. Nabana T. Togo H. J. Org. Chem.  2003,  68:  6424 
    Google Scholar
  • 4h Ueno M. Togo H. Synthesis  2004,  2673 
    Google Scholar
  • 5 Wipf P. Venkatraman S. J. Org. Chem.  1996,  61:  8004 
    CrossrefPubMedGoogle Scholar
  • 6a Togo H. Hoshina Y. Muraki T. Nakayama H. Yokoyama M. J. Org. Chem.  1998,  63:  5193 
    Google Scholar
  • 6b Katohgi M. Togo H. Yamaguchi K. Yokoyama M. Tetrahedron  1999,  55:  14885 
    Google Scholar
  • 6c Harada Y. Togo H. Yokoyama M. J. Org. Chem.  2000,  65:  926 
    Google Scholar
  • 6d Misu Y. Togo H. Org. Biomol. Chem.  2003,  1:  1342 
    Google Scholar
  • 6e Akiike J. Yamamoto Y. Togo H. Synlett  2007,  2168 
    Google Scholar
  • 6f Kawano Y. Togo H. Synlett  2008,  217 
    Google Scholar
  • 7 Koser GF. Sun G. Porter CW. Youngs WJ. J. Org. Chem.  1993,  58:  7310 
    CrossrefGoogle Scholar
  • 9 Singh CB. Ghosh H. Murru S. Patel BK. J. Org. Chem.  2008,  73:  2924 
    CrossrefPubMedGoogle Scholar
  • 10 Ishida M. Nakanishi H. Kato S. Chem. Lett.  1984,  1691 
    CrossrefGoogle Scholar
8

Typical Procedure for Preparation of 1 H -1-(1′-Hexynyl)-5-methyl-1,2,3-benziodoxathiole 3,3-Dioxide A mixture of 1H-1-hydroxy-5-methyl-1,2,3-benziodoxa-thiole 3,3-dioxide (5 mmol), PTSA˙H2O (5 mmol), and 1-hexyne (25 mmol) in MeCN (40 mL) was refluxed for 20 h. After removal of the solvent to obtain an oil, a solution of the oil in CHCl3 (200 mL) was washed with 5% NaHCO3 (80 mL) and H2O (3 × 50 mL), and was concentrated to a solid. Recrystallization of the solid with a mixture of CH2Cl2 (30 mL), Et2O (100 mL), and hexane (60 mL) gave 1H-1-(1′-hexynyl)-5-methyl-1,2,3-benziodoxathiole 3,3-dioxide in 53% yield.
1 H -1-(1′-Hexynyl)-5-methyl-1,2,3-benziodoxathiole 3,3-Dioxide (R =  n -Bu) Mp 164-166 ˚C (dec.); lit.7 179-181 ˚C (dec.). IR (Nujol): 2166 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 8.01(s, 1 H), 7.92 (d, J = 8.5 Hz, 1 H), 7.47 (d, J = 8.7 Hz, 1 H), 2.73 (t, J = 7.2 Hz, 2 H), 2.50 (s, 3 H), 1.61-1.74 (m, 2 H), 1.43-1.55 (m, 2 H), 0.98 (t, J = 7.4 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 143.7, 141.6, 135.1, 130.8, 126.8, 115.5, 105.8, 29.9, 28.5, 22.1, 20.8, 20.6, 13.5.
1 H -1-(1′-Octynyl)-5-methyl-1,2,3-benziodoxathiole 3,3-Dioxide (R =  n -C 6 H 13 ) Mp 150 ˚C (dec.); lit.7 152-154 ˚C (dec.). IR (Nujol): 2168 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 8.04 (s, 1 H), 7.90 (d, J = 8.7 Hz, 1 H), 7.48 (dd, J = 1.6, 8.6 Hz, 1 H), 2.73 (t, J = 7.1 Hz, 2 H), 2.51 (s, 3 H), 1.64-1.74 (m, 2 H), 1.42-1.52 (m, 2 H), 1.30-1.40 (m, 4 H), 0.92 (t, J = 7.0 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 143.8, 141.5, 135.0, 130.8, 126.6, 115.5, 105.8, 31.1, 28.5, 28.4, 27.8, 22.4, 20.9, 20.7, 14.0.
1 H -1-(1′-Phenylethynyl)-5-methyl-1,2,3-benziodoxa-thiole 3,3-Dioxide (R = Ph) Mp 217-219 ˚C (dec.); lit.7 221-223 ˚C (dec.). IR (Nujol): 2160 cm-¹. ¹H NMR (400 MHz, DMSO-d 6, TMS): δ = 8.12 (d, J = 8.4, 1 H), 7.76-7.81(m, 3 H), 7.53-7.67 (m, 4 H), 2.45 (s, 3 H). ¹³C NMR (100 MHz, DMSO-d 6, TMS): δ = 142.6, 142.4, 135.0, 133.0, 131.6, 129.1, 129.1, 128.9, 119.4, 107.7, 107.2, 41.3, 20.2.
Typical Procedure for Preparation of Thiazoles
To a solution of thiobenzamide (0.48 mmol) in THF (2 mL) were added K2CO3 (0.92 mmol) and 1H-1-(1′-phenyl-ethynyl)-5-methyl-1,2,3-benziodoxathiole 3,3-dioxide (0.4 mmol). The obtained mixture was stirred at 45 ˚C overnight under argon atmosphere. After the reaction, the mixture was filtered to remove potassium 2-iodo-5-methyl-benzene-sulfonate quantitatively. After evaporation of the filtrate, the residue was chromatographed on SiO2 (eluent: hexane-CHCl3, 1:1) to afford pure 1,4-diphenylthiazole in 65% yield.
2,4-Diphenylthiazole Mp 91-92 ˚C; lit.¹0 91-92 ˚C. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.98-8.09 (m, 4 H), 7.41-7.51 (m, 6 H), 7.35 (t, J = 7.4 Hz, 1 H).
Regeneration of Potassium 2-Iodo-5-methylbenzene-sulfonate to 1 H -1-Hydroxy-5-methyl-1,2,3-benziod-oxathiole 3,3-Dioxide Hydrogen peroxide (33%, 1.3 mL) was added dropwise to a solution of acetic anhydride (1.2 mL) at 0 ˚C. The obtained mixture was stirred overnight. After the reaction, the mixture was added dropwise to a stirred mixture of potassium
2-iodo-5-methylbenzenesulfonate (2.4 mmol) in AcOH (4 mL) and concd H2SO4 (1.2 mL) while keeping the temperature at 10-15 ˚C. The mixture was stirred at this temperature for 1 h and overnight at r.t. After the reaction, the precipitate was filtered to give 1H-1-hydroxy-5-methyl-1,2,3-benziodoxathiole 3,3-dioxide in 50-60% yield.
2-Phenyl-4-butylthiazole
Oil. IR(neat): 2956, 2929, 2859, 1516, 1498, 1460, 1436, 1244, 1004, 763, 689 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.93 (dd, J = 1.4, 8.0 Hz, 2 H), 7.38-7.45 (m, 3 H), 6.86 (s, 1 H), 2.83 (t, J = 7.8 Hz, 2 H), 1.70-1.80 (m, 2 H), 1.37-1.49 (m, 2 H), 0.96 (t, J = 7.4 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.4, 158.9, 133.9, 129.7, 128.8, 126.5, 112.6, 31.4, 31.3, 22.4, 13.9. HRMS-FAB: m/z calcd for C13H16NS [M + H]: 218.1003; found: 218.1006.
2-Methyl-4-butylthiazole
Oil. IR(neat): 3427, 2956, 2929, 2859, 1637, 1523, 1457, 1183, 1133, 730, 560, 526 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 6.69 (s, 1 H), 2.67-2.76 (m, 5 H), 1.62-1.73 (m, 2 H), 1.32-1.44 (m, 2 H), 0.93 (t, J = 7.4 Hz, 3 H).¹³C NMR (100 MHz, CDCl3, TMS): δ = 165.2, 157.3, 111.9, 31.4, 31.2, 22.4, 19.1, 13.9. HRMS-FAB: m/z calcd for C8H14NS [M + H]: 156.0847; found: 156.0837.
2-(4-Methylphenyl)-4-butylthiazole
Oil. IR(neat): 2955, 2928, 2859, 1509, 1457, 1246, 1007, 818, 735, 711 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.82 (d, J = 8.2 Hz, 2 H), 7.22 (d, J = 8.0 Hz, 2 H), 6.82 (s, 1 H), 2.81 (t, J = 7.7 Hz, 2 H), 2.38 (s, 3 H), 1.69-1.79 (m, 2 H), 1.36-1.48 (m, 2 H), 0.96 (t, J = 7.4 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.6, 158.7, 139.8, 131.3, 129.5, 126.4, 112.1, 31.4, 31.3, 22.4, 21.4, 13.9. HRMS-FAB: m/z calcd for C14H18NS [M + H]: 232.1160; found: 232.1161.
2-(4-Methoxyphenyl)-4-butylthiazole
Oil. IR(neat): 2859 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.87 (d, J = 8.9 Hz, 2 H), 6.94 (d, J = 9.0 Hz, 2 H), 6.79 (s, 1 H), 3.85 (s, 3 H), 2.81 (t, J = 7.7 Hz, 2 H), 1.68-1.80 (m, 2 H), 1.36-1.48 (m, 2 H), 0.96 (t, J = 7.3 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.5, 161.0, 158.7, 128.1, 127.1, 114.3, 111.8, 55.5, 31.6, 31.5, 22.6, 14.1. HRMS-FAB: m/z calcd for C14H18NOS [M + H]: 248.1109; found: 248.1119.
2-(4-Nitrophenyl)-4-butylthiazole
Mp 47-48 ˚C. IR (Nujol): 1522, 1345, 851 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 8.29 (d, J = 8.9 Hz, 2 H), 8.11 (d, J = 9.2 Hz, 2 H), 7.03 (s, 1 H), 2.85 (t, J = 7.7 Hz, 2 H), 1.71-1.81 (m, 2 H), 1.38-1.49 (m, 2 H), 0.97 (t, J = 7.4 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 164.2, 160.1, 148.2, 139.4, 127.0, 124.2, 115.0, 31.3, 22.3, 13.9. HRMS-FAB: m/z calcd for C13H15N2O2S [M + H]: 263.0854; found: 263.0838.
2-Amino-4-butylthiazole Oil. IR (Nujol): 3436, 1607, 1521, 1113, 696 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 6.08 (s, 1 H), 4.91 (s, 2 H), 2.53 (t, J = 7.8 Hz, 2 H), 1.56-1.68 (m, 2 H), 1.30-1.43 (m, 2 H), 0.92 (t, J = 7.4 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.3, 102.5, 102.5, 31.7, 31.2, 22.7, 14.2. HRMS-FAB: m/z calcd for C7H13N2S [M + H]: 157.0799; found: 157.0811.
2-Phenyl-4-hexylthiazole
Oil. IR(neat): 2926, 2856, 1517, 1458, 1239, 1003, 763, 689 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.94 (dd, J = 1.7, 7.8 Hz, 2 H), 7.36-7.47 (m, 3 H), 6.87 (s, 1 H), 1.70-1.82 (m, 2 H), 1.27-1.47 (m, 6 H), 0.89 (t, J = 7.1 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.4, 158.9, 133.9, 129.7, 128.8, 126.5, 112.6, 31.7, 31.7, 29.2, 29.0, 22.6, 14.1. HRMS-FAB: m/z calcd for C15H20NS [M + H]: 246.1316; found: 246.1315.
2-Methyl-4-hexylthiazole
Oil. IR(neat): 2955, 2926, 2856, 1523, 1457, 1183, 728 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 6.69 (s, 1 H), 2.67-2.75 (m, 5 H), 1.62-1.75 (m, 2 H), 1.23-1.45 (m, 6 H), 0.88 (t, J = 7.0 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 165.2, 157.4, 111.9, 31.6, 31.6, 29.2, 29.0, 22.6, 19.1, 14.1. HRMS-FAB: m/z calcd for C10H18NS [M + H]: 184.1160; found: 184.1167.
2-(4-Methylphenyl)-4-hexylthiazole
Oil. IR(neat): 2926, 2856, 1509, 1457, 1247, 1005, 817, 711 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.82 (d, J = 8.3 Hz, 2 H), 7.22 (d, J = 7.8 Hz, 2 H), 6.82 (s, 1 H), 2.80 (t, J = 7.6 Hz, 2 H), 2.38 (s, 3 H), 1.70-1.81 (m, 2 H), 1.27-1.46 (m, 6 H), 0.89 (t, J = 7.1 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.6, 158.7, 139.9, 131.3, 129.5, 126.4, 112.1, 31.7, 31.7, 29.2, 29.0, 22.6, 21.4, 14.1. HRMS-FAB: m/z calcd for C16H22NS [M + H]: 260.1473; found: 260.1493.
2-(4-Methoxyphenyl)-4-hexylthiazole
Oil. IR(neat): 2855 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.87 (d, J = 9.0 Hz, 2 H), 6.94 (d, J = 8.8 Hz, 2 H), 6.79 (s, 1 H), 3.85 (s, 3 H), 2.80 (t, J = 7.8 Hz, 2 H), 1.69-1.80 (m, 2 H), 1.25-1.45 (m, 6 H), 0.89 (t, J = 6.9 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 160.8, 158.6, 134.0, 127.9, 126.9, 114.1, 111.7, 55.4, 31.7, 31.7, 29.2, 29.0, 22.6, 14.1. HRMS-FAB: m/z calcd for C16H22NOS [M + H]: 276.1422; found: 276.1401.
2-(4-Nitrophenyl)-4-hexylthiazole
Mp 45-46 ˚C. IR (Nujol): 1523, 1339, 852 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 8.28 (d, J = 8.8 Hz, 2 H), 8.10 (d, J = 9.1 Hz, 2 H), 7.03 (s, 1 H), 2.84 (t, J = 7.8 Hz, 2 H), 1.72-1.81 (m, 2 H), 1.30-1.45 (m, 6 H), 0.90 (t, J = 7.8 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 164.2, 160.1, 148.2, 139.4, 127.0, 124.2, 115.0, 31.6, 31.6, 29.1, 28.9, 22.6, 14.1. HRMS-FAB: m/z calcd for C15H19N2O2S [M + H]: 291.1167; found: 291.1169.
2-Amino-4-hexylthiazole Mp 45-46 ˚C. IR (Nujol): 3432, 3235, 1606, 1508, 1103, 706 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 6.08 (s, 1 H), 4.92 (s, 2 H), 2.52 (t, J = 6.9 Hz, 2 H), 1.56-1.68 (m, 2 H), 1.24-1.39 (m, 6 H), 0.88 (t, J = 6.9 Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.0, 153.7, 102.2, 31.7, 31.6, 29.0, 28.7, 22.6, 14.1. HRMS-FAB: m/z calcd for C9H17N2S [M + H]: 185.1112; found: 185.1106.
2-Phenyl-4-butylthiazole
Oil. IR(neat): 2956, 2929, 2859, 1516, 1498, 1460, 1436, 1244, 1004, 763, 689 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.93 (dd, J = 1.4, 8.0 Hz, 2 H), 7.38-7.45 (m, 3 H), 6.86 (s, 1 H).
2-Methyl-4-phenylthiazole Mp 60 ˚C; lit.4h 64 ˚C. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.87 (d, J = 8.3 Hz, 2 H), 7.41 (t, J = 7.5 Hz, 2 H), 7.32 (t, J = 7.5 Hz, 1 H), 7.31 (s, 1 H), 2.78 (s, 3 H).
2-(4-Methylphenyl)-4-phenylthiazole Mp 126 ˚C. IR (Nujol): 974, 815, 741, 690, 676 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 8.00 (d, J = 8.2 Hz, 2 H), 7.94 (d, J = 8.2 Hz, 2 H), 7.41-7.48 (m, 3 H), 7.35 (t, J = 7.3 Hz, 1 H), 7.26 (d, J = 6.5 Hz, 2 H), 2.41 (s, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 168.0, 156.1, 140.3, 134.6, 131.1, 129.6, 128.7, 128.1, 126.5, 126.4, 112.1, 21.4. HRMS-FAB: m/z calcd for C16H14NS [M + H]: 252.0847; found: 252.0851.
2-(4-Methoxyphenyl)-4-phenylthiazole Mp 97-98 ˚C. IR (Nujol): 1256, 1173, 979, 833, 738 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.96-8.02 (m, 4 H), 7.40-7.48 (m, 3 H), 7.34 (t, J = 7.4 Hz, 1 H), 6.98 (d, J = 8.9 Hz, 2 H), 3.88 (s, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 177.6, 161.4, 134.9, 133.6, 128.9, 128.3, 127.0, 126.6, 115.0, 114.5, 111.9, 55.7. HRMS-FAB: m/z calcd for C16H14NOS [M + H]: 268.0796; found: 268.0802.
2-(4-Nitrophenyl)-4-phenylthiazole Mp 164-165 ˚C. IR (Nujol): 1514, 1339, 849 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 8.33 (d, J = 8.9 Hz, 2 H), 8.22 (d, J = 8.9 Hz, 2 H), 8.00 (d, J = 8.2 Hz, 2 H), 7.63 (s, 1 H), 7.48 (t, J = 7.4 Hz, 2 H), 7.40 (t, J = 7.4 Hz, 1 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 164.8, 157.3, 148.4, 139.1, 133.9, 128.9, 128.7, 127.1, 126.5, 124.3, 114.6. HRMS-FAB: m/z calcd for C15H11N2O2S [M + H]: 283.0541; found: 283.0547.
2-Amino-4-phenylthiazole Mp 145-147 ˚C. IR (Nujol): 3433, 1595, 1518, 1038, 714 cm-¹. ¹H NMR (400 MHz, CDCl3, TMS): δ = 7.78 (d, J = 8.0 Hz, 2 H), 7.38 (t, J = 7.6 Hz, 2 H), 7.29 (t, J = 7.4 Hz, 1 H), 6.73 (s, 1 H), 5.03 (s, 2 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.0, 151.3, 134.6, 128.6, 127.7, 126.0, 102.9. HRMS-FAB: m/z calcd for C9H9N2S [M + H]: 177.0486; found: 177.0485.